Company & Sponsor Intelligence

HealthPartners Institute

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting1

Completed4

Countries1

Therapeutic footprint

alzheimersanxietydementia_othermigraine_headacheneuromuscularother_psychiatryparkinsons

Indexed studies

NCT06285448Feasibility of Lecanemab Registry and Clinical Outcome Measures
alzheimers · United StatesENROLLING_BY_INVITATION

NCT04369911Acupuncture in Traumatic Brain Injury
migraine_headache · United StatesNA

NCT01372670Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
anxiety · United StatesPHASE4

NCT06491238Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
neuromuscular · United StatesNA

NCT06385392Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.
parkinsons · United StatesCOMPLETED

NCT05860647Transmagnetic Stimulation Pilot in Primary Progressive Aphasia
other_psychiatry · United StatesNA

NCT04062227Mindfulness Based Dementia Care Study
dementia_other · United StatesCOMPLETED

NCT06999304Pilot TMS in Mild TBI
migraine_headache · United StatesNA

NCT06999330TMS in Anxiety-Parkinson's Disease
parkinsons · United StatesNA

NCT02503501Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
alzheimers · United StatesPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →